Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that oestrogen hormone replacement therapy products are accessible to those requiring them.
The Department has well established procedures to deal with medicine shortages and discontinuations should they arise. We work with pharmaceutical companies and trade bodies to regularly discuss the issue of hormone replacement therapy (HRT) supply. While there are a limited number of oestrogen only and oestrogen containing HRT products currently in shortage, alternative products remain available.